Clinical Trial Update: Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing telmisartan to placebo in patients with mild-to-moderate hypertension assessing natriuretic effects; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED